Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Ipilimumab targets the cytotoxic T lymphocyte-associated protein 4 (CTLA-4) receptor, enhancing the immune response against the tumor mass.
Ipilimumab is a fully human monoclonal antibody that blocks Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) to augment antitumor T-cell responses.
Ipilimumab Active Particularly in Pts with Small & Asymptomatic Brain Metastases
see also:
[Anti-CTLA-4 / CTLA-4 antibodies](brain://M1_BrScGZ0O3qgeB5-tC0…